Breaks Categories: News

TuesdayJan 12, 2021 9:10 am

NetworkNewsBreaks – Friendable Inc. (FDBL) Announces Record Number of Artist Sign-Ups, Plans to Scale on ‘All Fronts’ in New Year

Friendable (OTC: FDBL) wrapped up the year 2020 with more than 700 new artists joining its exclusive Fan Pass platform since its July launch. The mobile technology and marketing company, which is focused on connecting and engaging users through proprietary mobile and desktop applications, reported that more artists are signing up every day for Fan Pass. FDBL noted that the growth is coming primarily from up-and-coming artists and middle-tier performers as well as those seeking to release previous performances, or gigs, with live-streaming or virtual events. The platform also offers artists the opportunity to sell merchandise and schedule and manage…

Continue Reading

MondayJan 11, 2021 1:43 pm

NetworkNewsBreaks – Knightscope Inc. Expresses Gratitude to Investors

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that that it has over 18,000 investors! In the update, the company expressed its gratitude to its investors for their unwavering support through both the good and tough times on the rollercoaster of a ride that is a startup. Knightscope is excited for 2021 as it continues to grow the company and wishes everyone a safe and rewarding year. To view the full update, visit https://nnw.fm/UL9DM About Knightscope Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security…

Continue Reading

MondayJan 11, 2021 1:23 pm

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at H.C. Wainwright BIOCONNECT 2021

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced that management will present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference. According to the update, the presentation is now available for on-demand listening by visiting https://nnw.fm/7YaWa. In addition, the press release can also be viewed on the company’s website. To view the full press release, visit https://nnw.fm/I5VOe About Processa Pharmaceuticals Inc. The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical…

Continue Reading

MondayJan 11, 2021 12:57 pm

NetworkNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Announces Strategic Appointments of Chiefs Kathleen O’Toole and Sylvia Moir

Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, today announced the appointment of Kathleen O’Toole, retired commissioner of Boston and Seattle Police Departments, and Sylvia Moir, retired chief of Tempe Police Department, to join the company’s public safety technology development and agency relations efforts. “As WRAP continues to drive innovations in public safety, we are proud to welcome two highly accomplished leaders,” said Tom Smith, president and interim CEO at WRAP. “Ret. Chief O’Toole and Ret. Chief Moir each hold decades of career experience in law enforcement as well as historic positions as inaugural female chiefs of their…

Continue Reading

MondayJan 11, 2021 12:30 pm

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) to Present at CES 2021 Virtual Conference

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that it will exhibit virtually at the CES 2021 all digital event, Jan. 12-14, 2021. According to the update, the company will present the latest developments to its proprietary automatic calibration software solution, designed to ensure that stereo cameras remain calibrated regardless of their configuration or position, to create accurate and continuous depth perception. In addition, Foresight will discuss how its unique solution enables separation of stereo cameras in order to allow flexible placement of cameras on the vehicle, increase the baseline between the cameras,…

Continue Reading

MondayJan 11, 2021 12:10 pm

NetworkNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at the Biotech Showcase(TM) Digital 2021 Conference

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will present at the Biotech Showcase(TM) Digital 2021 Conference. According to the update, the conference is taking place online between January 11-15 and will feature prerecorded sessions of company presentations. Dr. James Woody, Chief Executive Officer, will provide an overview of 180 Life Sciences and the company’s progress in key programs. In addition, 180 Life Sciences will host one-on-one meetings with investors and…

Continue Reading

MondayJan 11, 2021 11:47 am

NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces New CFO, General Counsel

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) chairman and CEO Roger McIntyre today announced the company's appointment of Stephen R. Brooks as its new chief financial officer and Peter Rizakos as the firm's new general counsel. According to the update, these appointments complete the company's new top management team put into place by Dr. McIntyre and the Champignon Board of Directors.  "These new management additions ready us for the future where the Company's clinical products and services will help meet the enormous public need that is creating significant public demand for improved, ketamine-based treatments that are capable of rapid response…

Continue Reading

MondayJan 11, 2021 11:19 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) Announces Strategic Partnership with Kernel

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, is excited to announce that it has entered into an agreement with neurotech pioneer HI, LLC dba Kernel (“Kernel”) to leverage its innovative technology, Kernel Flow (“Flow”), for its upcoming sponsored clinical work. “Access to Kernel’s innovative Flow technology adds another exciting dimension to the investigative work that Cybin is doing to develop breakthrough treatments for mental health disorders such as depression and addiction. Currently, clinical investigators rely on limited subjective information from patients. The ability to collect quantitative data from our sponsored drug development programs is potentially…

Continue Reading

MondayJan 11, 2021 9:52 am

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Announces Application to List on NASDAQ

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced that it has taken a significant step to enhance its investor profile by launching a new capital markets strategy focused on the United States. As a result and per the update, the Company has applied to list its common shares on the NASDAQ Capital Market (“NASDAQ”). “With our sustained and continuous growth, this is a natural step forward,” said PlantX founder, Sean Dollinger. “We’re looking forward to the opportunities that this move can create for the plant-based movement.” To view the full press release, visit https://nnw.fm/264GD About PlantX Life Inc.…

Continue Reading

FridayJan 08, 2021 12:19 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces $3M Registered Direct Offering

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has entered into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of 3,650,840 shares of its common stock at a purchase price of $0.842 per share. The company expects to secure gross proceeds of approximately $3.0 million in the registered direct offering priced at-the-market under Nasdaq rules. Predictive Oncology has also agreed to issue to the investors unregistered warrants to purchase an aggregate of up to 1,825,420 shares of…

Continue Reading